Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo
's stock had its "underperform" rating restated by research analysts at Wells Fargo in a report issued on Friday, MarketBeat.com reports. Shares of Valeant Pharmaceuticals Intl traded down 0.03% during midday trading on Friday, reaching $32.35.
from Biotech News
0 Comments